Does pharmacological intervention prevent or delay the onset of psoriatic arthritis among psoriasis patients?

The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial

(2023) Christopher T. Ritchlin et al.   Trials

EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis

(2023) Alen Zabotti et al.   ANNALS OF THE RHEUMATIC DISEASES

Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study

(2023) Shikha Singla et al.   Lancet Rheumatology

Does biologic therapy impact the development of PsA among patients with psoriasis?

(2022) Elana Meer et al.   ANNALS OF THE RHEUMATIC DISEASES

Paradoxical reactions to biologicals for psoriasis

(2022) Elisa Camela et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights

(2021) Qiao Zhou et al.   Frontiers in Immunology

Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis

(2021) Paolo Gisondi et al.   ANNALS OF THE RHEUMATIC DISEASES

Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis

(2021) Maria Laura Acosta Felquer et al.   ANNALS OF THE RHEUMATIC DISEASES

Psoriatic arthritis incidence among patients receiving biologic medications for psoriasis: A nested case control study

(2021) Yael Shalev Rosenthal et al.   Arthritis & Rheumatology

New-Onset Psoriatic Arthritis under Biologics in Psoriasis Patients: An Increasing Challenge?

(2021) Matteo Megna et al.   Biomedicines

Regression of peripheral subclinical enthesopathy in therapy-naïve patients treated with Ustekinumab for moderate-to-severe chronic plaque psoriasis

(2018) Laura Savage et al.   Arthritis & Rheumatology